tm logo
COVERMYMEDS
Live/Registered
REGISTERED

on 31 Dec 2024

Last Applicant/ Owned by

910 John Street

Columbus

OH

43222

Serial Number

90818802 filed on 08th Jul 2021

Registration Number

7634132 registered on 31st Dec 2024

in the Principal Register

Correspondent Address

Auma N. Reggy

Auma N. Reggy MCKESSON CORPORATION

ATLANTA, GA 30329

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

COVERMYMEDS

Providing temporary use of a web-based software application for use in providing support for pharmacies and health systems that integrates with pharmacy management systems to facilitate dispensing of pharmaceuticals via remote prescription verification, audit trails with images of dispensed drug, alerts to avoid duplicate patient therapy, allergies, and drug interactions; Software as a service (SA Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication


First Use Date in General

31st Mar 2008

First Use Date in Commerce

31st Jul 2008

Class [044]
Medical, Beauty & Agricultural Services


Providing medical advice and information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance; medication counseling, namely providing information about taking medication, medication side-effects, allergic sensitivity to medications, drug interactions, medication tolerance, and alternate medication brands and generics


First Use Date in General

31st Mar 2008

First Use Date in Commerce

31st May 2008

Class [042]
Computer & Software Services & Scientific Services


Providing temporary use of a web-based software application for use in providing support for pharmacies and health systems that integrates with pharmacy management systems to facilitate dispensing of pharmaceuticals via remote prescription verification, audit trails with images of dispensed drug, alerts to avoid duplicate patient therapy, allergies, and drug interactions; Software as a service (SAAS) services featuring software for facilitating the prescription of, and access to covered specialty medications and medical treatments by enabling intra provider-insurer-pharmacy communications for purposes of investigating and verifying patient-specific benefits coverage, for processing prior medical authorizations, for locating and facilitating patient access to financial assistance, for scheduling laboratory tests and first dose observations, for transmitting prescriptions to a patient's preferred pharmacy, and for supporting pharmaceutical companies in risk evaluation and mitigation strategy programs, and, as related to the above, specifically excluding software permitting health care providers and patients to communicate via a customized private website to collect, analyze, manage, share, report or compare patient data, rehabilitation tracking and patient progress; Software as a service featuring software for integration of medical software with drug interaction references and recommendations from medical databases; Software as a service (SAAS) namely, hosting an online software platform for use by others that provides online price comparisons, cost analysis, coupons, and price quotations of pharmaceuticals and over the counter medications for consumers, providers, administrators, and other participants in the healthcare industry; Software as a service (SAAS) services featuring software for use by medical care providers, pharmacists, and benefit providers for utilizing, aggregating, analyzing, displaying, and updating medical health record data analytics, for use in prior authorization support, prescription benefit support, prescription decision support, and medical care support to improve clinical outcomes; Software as a service (SAAS) services featuring software for the purpose of integrating medical information in the fields of pharmaceuticals, drug interactions, and treatment guidelines for the purpose of reducing the time and effort required from all stakeholders to start specialty therapy with the goal of improving patient outcomes


First Use Date in General

31st Mar 2008

First Use Date in Commerce

31st Jul 2008

Class [036]
Insurance & Financial Services


Financial administration of pharmaceutical manufacturer program that redeploys rebate funds directly to underinsured or uninsured consumers at the pharmacy counter; providing a patient financial assistance and financial support program for patients and their healthcare providers for the purpose of facilitating good health, namely, providing financial information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance


First Use Date in General

31st Mar 2008

First Use Date in Commerce

31st Jul 2008

Class [038]
Communications Services


Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments, and referrals that allow direct transaction and payment communications between healthcare providers, pharmacies, and payers


First Use Date in General

31st Mar 2008

First Use Date in Commerce

31st Jul 2008

Mark Details


Serial Number

No 90818802

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
31st Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
31st Dec 2024REGISTERED-PRINCIPAL REGISTER
11th Dec 2024STATEMENT OF USE PROCESSING COMPLETE
11th Dec 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11th Dec 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Jun 2024SOU EXTENSION 1 FILED
12th Jun 2024SOU EXTENSION 1 GRANTED
12th Jun 2024SOU TEAS EXTENSION RECEIVED
12th Jun 2024TEAS STATEMENT OF USE RECEIVED